Aug 17 (Reuters) - Corporate Travel Management Ltd (CTD) :
- FY NET PROFIT ATTRIBUTABLE A$3.1 MILLION VERSUS LOSS OF A$55.4 MILLION
- FY REVENUE FROM ORDINARY ACTIVITIES A$377.4 MILLION VERSUS A$174.0 MILLION
- FOR YEAR TOTAL TRANSACTION VALUE A$5.07 BILLION VERSUS A$1.61 BILLION
- REVENUE IN JUNE 2022 EQUATED TO 74% OF MONTHLY AVERAGE PRO-FORMA REVENUE FOR FY19
- FINAL DIVIDEND OF 5.0 AU CENTS PER SHARE
- EXPECTS BOTH CAPACITY CONSTRAINTS AND CHINA'S OPENING TO BE PROGRESSIVELY RESOLVED DURING FY23
- PATH FROM ANNUALISED 4Q22 UNDERLYING EBITDA OF A$143M TO FY24'S A$265M NOT EXPECTED TO BE LINEAR THROUGH FY23
- CONFIDENT OF IMPROVING CORPORATE TRAVEL DEMAND IN FY23
- IN ASIA, REDUCTION IN HONG KONG'S QUARANTINE PERIOD HAS CREATED IMMEDIATE STEP-UP IN TRAVEL ACTIVITY
- ANZ HAS SHOWN CONTINUED RESILIENCE WITH NO SLOW-DOWN IN TRAVEL ACTIVITY, WITH TTV AT PRE-COVID LEVELS
- Forums
- ASX - By Stock
- CTD
- News: CTD Corporate Travel Management FY Net Profit Attributable A$3.1 Mln
CTD
corporate travel management limited
Add to My Watchlist
0.25%
!
$16.08

News: CTD Corporate Travel Management FY Net Profit Attributable A$3.1 Mln
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.08 |
Change
-0.040(0.25%) |
Mkt cap ! $2.352B |
Open | High | Low | Value | Volume |
$16.13 | $16.30 | $15.98 | $5.950M | 368.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 958 | $16.04 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.14 | 1660 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 958 | 16.040 |
1 | 1000 | 16.030 |
1 | 2000 | 16.010 |
1 | 1500 | 15.970 |
1 | 1000 | 15.950 |
Price($) | Vol. | No. |
---|---|---|
16.140 | 1660 | 1 |
16.300 | 3073 | 3 |
16.360 | 2000 | 1 |
16.400 | 4000 | 3 |
16.450 | 10763 | 3 |
Last trade - 16.17pm 21/08/2025 (20 minute delay) ? |
Featured News
CTD (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online